Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Melanoma 4Carcinoma, Renal Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Kidney Neoplasms 3Pancreatic Neoplasms 2Multiple Myeloma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia 2Warts 1Small Cell Lung Carcinoma 1Recurrence 1Papilloma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lung Neoplasms 1HIV Infections 1Colorectal Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 25Mycophenolic Acid 24Whole-Body Irradiation 23Busulfan 21Tacrolimus 19Cyclosporine 19Antilymphocyte Serum 14Methotrexate 13Imatinib Mesylate 12Cord Blood Stem Cell Transplantation 11Melphalan 10Dasatinib 10Cyclosporins 8nilotinib 7Methylprednisolone 7Etoposide 7Radiotherapy 6Filgrastim 6Alemtuzumab 6Sirolimus 5thymoglobulin 4sargramostim 4bosutinib 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4fludarabine 3Thiotepa 3Rituximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Chronic-Phase × Interferon-alpha × Clear all
NCT00015847 2025-08-22

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
25 enrolled 8 charts
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00363649 2018-11-13

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
36 enrolled 13 charts
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡